Topical Nigella sativa L. product: a new candidate for the management of diabetic peripheral neuropathy.

Seyed-Ali KhodaieHaniyeh NikkhahNasim NamiranianMarzie AbotorabiMaryam AskariSaeed Hosein KhalilzadehAmidoddin Khatibi AghdaMohammad Kamalinejad

Published in: Inflammopharmacology (2023)

According to the results of this study, the topical use of N. sativa, compared to the current drugs, has acceptable improving effects on diabetic neuropathic patients.

Keyphrases

wound healing
end stage renal disease
type diabetes
ejection fraction
newly diagnosed
chronic kidney disease
patient reported outcomes